This is a $75,887 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI) to The University of Iowa for the NCI Patterns of Care Study regarding diagnosis year 2020 breast cancer and colorectal cancer cases. The study aims to describe the use of recommended biomarker tests, targeted therapies, and adjuvant treatments, as well as characterize care patterns and the impacts of the COVID-19 pandemic on cancer care. The University of Iowa will abstract data from medical records...
This is a federal contract award issued by the National Cancer Institute (NCI), a component of the National Institutes of Health, to The University of Iowa. The contract, valued at $103,941.64, is for a Surveillance, Epidemiology, and End Results (SEER) Linked Virtual Tissue Repository (VTR). The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. The University of Iowa has an ongoing relationship with the NCI through this contract as well as an Indefinite...
This federal contract award was issued by the National Cancer Institute, a civilian agency, to the University of Iowa. The contract has a ceiling value of $40,332.50 and is a firm fixed-price delivery order without a set-aside designation. The award supports the University of Iowa's provision of research, healthcare, education, and specialized services to various government agencies. The University of Iowa has a long history of academic excellence and research capabilities across many...
This is a federal contract award from the National Cancer Institute (NCI), part of the Department of Health and Human Services, to The University of Iowa. The contract, valued at $91,532.00, is for the NCI Patterns of Care Study to collect data on prostate, ovarian, and small intestinal cancers diagnosed in 2021. The study aims to describe the use of biomarker tests, targeted therapy, and other cancer treatment patterns, as well as the effects of the COVID-19 pandemic. The contract does not have...
This is a federal contract award by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to the University of Iowa. The $126,776 contract is a delivery order under the Surveillance Epidemiology and End Results (SEER) Program, which conducts cancer surveillance research and data collection. The University of Iowa, a public research university, is the prime contractor and will provide services related to the SEER program from its...
This federal contract award was issued by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to The University of Iowa. The $31,379.50 firm fixed-price delivery order is for "OTHER FUNCTIONS TASK ORDER #4 - GBV-C TESTING FOR THE GBV-C INFECTION & RISK IN THE NHL IN THE PLCO COHORT." The contract does not have a set-aside designation. This appears to be a task order issued against a larger indefinite delivery contract vehicle,...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to The University of Iowa. The $60,009.00 contract is for quality control of electronic pathology (e-path) results for stage-appropriate cases under the Surveillance, Epidemiology, and End Results (SEER) Program. The University of Iowa, a top public research university, has a track record of providing a wide range of specialized services and research to...
This is a federal contract award to The University of Iowa by the National Cancer Institute, a component of the National Institutes of Health (NIH), for a project titled "Patient Generated Health Data (PGHD) to Enhance SEER Data Collection." The contract has a period of performance from September 19, 2016 to September 18, 2017, with a ceiling value of $151,314.00. The contract is a delivery order under the Surveillance, Epidemiology, and End Results (SEER) program, a major NIH cancer...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded a $124,656 firm-fixed-price purchase order to the University of Hawaii Systems for the acquisition of cancer biospecimens and associated data. This sole-source award, which has no set-aside designation, will support the NCI's Center for Cancer Genomics' research on three major cancer types: Peripheral T Cell Lymphoma, Carcinomas of Unknown...
This is a cost-sharing definitive contract awarded by the National Cancer Institute (NCI) to The University of Iowa to support the Surveillance, Epidemiology and End Results (SEER) program. The $35,120,047.80 contract has an ultimate completion date of July 31, 2017 and does not have a set-aside designation. Under the contract, The University of Iowa serves as the prime contractor and has subcontracted with Mayo Clinic and Inspirata Canada Inc. (doing business as AIM) to provide cancer case...
This is a $123,721 firm fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to The University of Iowa. The contract is for the acquisition of 643 cancer biospecimens and associated data in support of NCI's Center for Cancer Genomics (CCG) research on peripheral T cell lymphoma, carcinomas of unknown primary, and refractory diffuse large-B cell lymphomas. The contract does not have a set-aside designation. The award references a prior sole-source Special Notice posting that identified The University of Iowa as the only known source capable of providing the required rare tumor specimens. This contract represents an ongoing relationship between NCI and The University of Iowa, which has previously supported NCI and other federal agencies through various research and laboratory services contracts and grants.